Mealey's PI/Product Liability - Most False Claims, Kickback Claims Survive In Federal Case Against Novartis

NEW YORK - A federal judge in New York on Aug. 7 allowed most of the government's false claims and kickback claims against Novartis Pharmaceutical Corp. for the marketing of Myfortic and Exjade to proceed but dismissed other claims without prejudice (United States of America ex rel. David M. Kester v. Novartis Pharmaceuticals Corporation, et al., No. 1:11-8196, S.D. N.Y.).

Access this news story on®